U.S. Specialized REITs Stock News

Gold Royalty Corp. recently reported its second-quarter and first-half 2026 results, with gold equivalent ounce production rising to 1,757 for the quarter and 3,677 for the half-year, alongside sales of US$6.73 million and net income of US$1.78 million in the quarter and US$3.55 million for the first six months. The company also reaffirmed its 2026 production guidance of 7,500 to 9,300 gold equivalent ounces, based on assumed gold and copper prices, underlining how its expanding royalty...

RadNet stock has delivered a strong 136.9% return over the past 5 years, yet today investors face mixed valuation signals as an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach screens the shares as undervalued while market multiples point to a richer price. Over 5 years RadNet has returned 136.9%, which puts extra focus on whether the current share price still leaves room for an attractive risk adjusted payoff. The recent FDA clearance for DeepHealth Breast Ultrasound...

RXO stock jumped about 7% to US$21.70 after the Q2 print, a sharp move for a freight brokerage that has frustrated investors over the past month with a roughly 19% slide. The reaction hinges on one thing: the margin story finally showed some relief, even as the company remained loss making. Adjusted earnings before interest, tax, depreciation and amortization came in at US$40 million and net income loss narrowed to US$9 million on US$1.8b of revenue. For a capital tight, cash hungry model,...

Amgen recently received a positive opinion from the European Medicines Agency’s CHMP to expand Repatha’s use to adults with or at high risk for atherosclerotic cardiovascular disease in Europe, following Phase 3 VESALIUS-CV data showing meaningful reductions in first major cardiovascular events and LDL-C levels. This expanded cardiovascular prevention use, if approved by the European Commission, could broaden Repatha’s eligible patient pool and reinforce Amgen’s position in treating...

In recent days, analysts’ forecasts for Amcor’s upcoming quarterly results have pointed to earnings of $1.20 per share, with revenues and both flexible and rigid packaging segments expected to grow meaningfully year over year. This upbeat view of broad-based segment growth suggests analysts see operational momentum across Amcor’s core packaging businesses rather than a narrow, one-off improvement. We’ll now examine how these stronger-than-expected earnings projections, particularly for rigid...

Duolingo (DUOL) is back in focus after its latest quarterly report and guidance. The company shared second quarter 2026 results together with revenue expectations for the third quarter and full year. See our latest analysis for Duolingo. Duolingo's latest earnings and guidance have come after a sharp move in the stock, with a 1 day share price return of 6.79% but a year to date share price decline of 25.83% and a 1 year total shareholder return that is down 64.65%. That mix of short term...

UFP Industries (UFPI) is back in focus after reporting second quarter 2026 results that showed higher sales but lower net income compared with a year earlier, along with fresh detail on its recent share repurchases. See our latest analysis for UFP Industries. The second quarter earnings release and confirmation of ongoing buybacks have coincided with a 13.29% 1 month share price return and an 11.45% 3 month share price return. However, the 1 year total shareholder return is down 2.43% and the...

Why RB Global Is Back On Investors' Radar After Q2 2026 RB Global (RBA) reported Q2 2026 results and a fresh update on its capital return plans, combining higher revenue and net income with a completed share buyback and a declared dividend. This mix of earnings information and cash returns to shareholders is drawing renewed attention to RB Global stock in early August 2026, especially as investors compare its profile with other business services companies. See our latest analysis for RB...

JD.com recently reported its Q2 FY2026 results on 13 August, giving investors fresh detail on its revenue trends, profitability, and the progress of its logistics and supply chain operations. The update also highlighted how JD.com’s push into higher-margin services and overseas markets is becoming an increasingly important driver of its long-term business mix. We’ll now examine how JD.com’s Q2 results and ongoing logistics expansion could influence the company’s broader investment...

Sprout Social stock has ripped higher, jumping 26% to US$10.34 after its Q2 release, as traders rushed to reprice a business that came into the print already recovering over the past three months. The headline is simple: profit quality is catching up to the growth story. Revenue reached US$123.8m while non GAAP operating margin widened to 12.9% and non GAAP free cash flow came in at US$8.3m. The bigger story now sits on a longer clock, as management has raised full year profit guidance and is...

DoorDash (NasdaqGS:DASH) reported early results from its internal AI tools for merchants and order processing, highlighting tangible operational effects. CEO Tony Xu said agentic order volume from third-party AI partners is still limited compared with DoorDash’s own AI-driven systems. The company cited merchant catalog automation and AI order agents as key areas where its in-house tools are already influencing how its marketplace runs. The update gives investors a fresh view on how applied...

Hilton Worldwide Holdings has delivered very strong share price gains over the past five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and traditional market multiples currently point to the stock trading at a premium. Hilton Worldwide Holdings has returned 163.4% over the last 5 years, which means existing shareholders have already seen a substantial re rating. Higher profit and revenue per available room expectations supported by upcoming World Cup related travel...

Neogen (NEOG) recently reported fourth quarter and full year results, with revenue broadly unchanged year over year and a sharply smaller net loss, and paired this with new revenue guidance for fiscal 2027. See our latest analysis for Neogen. Neogen’s latest earnings update and new fiscal 2027 revenue guidance have come alongside strong share price momentum, with a 30 day share price return of 23.87% and a year to date share price return of 63.86%. Over a longer horizon, the 1 year total...

Urban Outfitters stock has delivered a strong 111.3% return over the past three years, yet the current share price around US$76.92 still screens attractively against an intrinsic value estimate from a Discounted Cash Flow (DCF) model that points to roughly 21.6% undervaluation. At the same time, traditional earnings multiples suggest the stock is trading at about the right level, so investors are weighing a discounted intrinsic value signal against a market that already prices in solid...

Health Catalyst dropped about 25% to US$1.73 after its latest report, even though the headline numbers were not a collapse story. Q2 revenue landed at US$70.5 million and adjusted EBITDA came in at US$9.9 million, with adjusted EPS at US$0.04. The real jolt came from what happens next. The sale of the higher margin Vitalware unit, the shift to the Ignite platform and fresh guidance all reshape the earnings path from here. Investors may appreciate the recurring software revenue at Health...

In early August 2026, Zevra Therapeutics reported Q2 2026 results showing higher sales of US$39.66 million alongside lower net income of US$8.75 million compared with the prior year, while also highlighting strong US uptake of its Niemann-Pick disease type C therapy MIPLYFFA (arimoclomol). A separate publication of four-year, real-world data on arimoclomol in a broad Niemann-Pick disease type C population, including adults, adds clinically rich evidence that extends beyond prior pivotal...

Why Twist Bioscience Stock Is Back in Focus Twist Bioscience (TWST) moved back onto investors' radar after raising revenue guidance for fiscal 2026 and the fourth quarter, along with new commentary on demand for its DNA synthesis platform and product portfolio. The updated outlook was followed by a completed common stock offering, which added fresh capital but also expanded the share count. That combination of higher guidance and new equity makes timing and pricing key considerations for...

Roper Technologies (NasdaqGS:ROP) subsidiary Illumia has appointed Eric Schuster as Chief Product Officer. Schuster brings extensive AI and enterprise software leadership experience from senior roles at ADP and Ceridian/Dayforce. The appointment is expected to shape Illumia's product roadmap, with a focus on client-centric solutions and practical AI use cases. For investors watching how AI and vertical SaaS shape long term software portfolios, it can be useful to look at a wider group of...

Las Vegas Sands stock has fallen 29.8% year to date, yet current checks suggest the shares may now sit close to their intrinsic value rather than being clearly cheap or expensive. Year to date the share price is down 29.8%, which puts recent sentiment under pressure and makes today's valuation levels especially important for new money going into Las Vegas Sands. Recent commentary around Macau and Singapore softness can weigh on growth expectations, while continued strength in domestic gaming...

What the latest earnings, dividend and buyback mean for Yum China Holdings stock Yum China Holdings (YUMC) reported second quarter and first half 2026 results on 30 July, alongside a quarterly dividend declaration and an update on its long running share repurchase program. The company posted second quarter revenue of US$3,138 million and net income of US$244 million, with basic earnings per share from continuing operations of US$0.70. First half net income reached US$553 million. Alongside...

In late July 2026, Healthcare Realty Trust filed shelf registrations covering up to US$775.08 million of securities, reported a second-quarter 2026 net loss of US$43.51 million on US$281.85 million in revenue, affirmed a US$0.24 per-share dividend, and updated full-year 2026 guidance to a loss per share between US$0.15 and US$0.11. Alongside these filings and results, the company kept its dividend intact while having completed US$99.88 million of prior share repurchases, underscoring a...

Roku stock inched up about 2% after earnings, which might look like a routine move for a company often framed as either a streaming winner in waiting or an overhyped advertising platform. The headline is less subtle. Roku just posted roughly US$1.11 in basic earnings per share on quarterly revenue of about US$1.35b, building on a trailing 12 month profit profile that now shows more than US$355m in earnings from continuing operations. The market reaction so far feels restrained compared with...

On 4 August 2026, Westinghouse Electric Company announced a series of agreements with Amentum to support its APX nuclear technology platform, including AP1000 fleet deployment, AP300 small modular reactor development and licensing, and joint work on delivering 1‑gigawatt reactors at scale. This collaboration deepens Amentum’s role across the nuclear project lifecycle, aligning its engineering and regulatory expertise with Westinghouse’s APX platform to pursue repeatable, fleet‑based reactor...

Sarepta Therapeutics (NasdaqGS:SRPT) appointed Michael Severino, M.D., as Chief Executive Officer and member of the Board of Directors. Severino joins Sarepta Therapeutics after senior leadership and research roles at Tessera Therapeutics, Flagship Pioneering, AbbVie, Amgen, and Merck. The leadership change places an experienced physician executive at the top of the company at a time when investors are watching for potential shifts in focus and execution. Consider reviewing other companies...